Merck & Co., Inc. (MRK)
NYSE: MRK · IEX Real-Time Price · USD
131.48
+0.29 (0.22%)
May 20, 2024, 11:05 AM EDT - Market open
Merck & Co. Revenue
Merck & Co. had revenue of $61.40B in the twelve months ending March 31, 2024, with 6.11% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $15.78B with 8.89% year-over-year growth. In the year 2023, Merck & Co. had annual revenue of $60.12B with 1.40% growth.
Revenue (ttm)
$61.40B
Revenue Growth
+6.11%
P/S Ratio
5.41
Revenue / Employee
$852,806
Employees
72,000
Market Cap
333.09B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
| Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
| Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
| Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
| Dec 31, 2019 | 39.12B | -3.17B | -7.50% |
| Dec 31, 2018 | 42.29B | 2.17B | 5.41% |
| Dec 31, 2017 | 40.12B | 315.00M | 0.79% |
| Dec 31, 2016 | 39.81B | 309.00M | 0.78% |
| Dec 31, 2015 | 39.50B | -2.74B | -6.48% |
| Dec 31, 2014 | 42.24B | -1.80B | -4.08% |
| Dec 31, 2013 | 44.03B | -3.23B | -6.84% |
| Dec 31, 2012 | 47.27B | -780.00M | -1.62% |
| Dec 31, 2011 | 48.05B | 2.06B | 4.48% |
| Dec 31, 2010 | 45.99B | 18.56B | 67.66% |
| Dec 31, 2009 | 27.43B | 3.58B | 15.00% |
| Dec 31, 2008 | 23.85B | -347.70M | -1.44% |
| Dec 31, 2007 | 24.20B | 1.56B | 6.90% |
| Dec 31, 2006 | 22.64B | 624.10M | 2.84% |
| Dec 31, 2005 | 22.01B | -960.90M | -4.18% |
| Dec 31, 2004 | 22.97B | 486.90M | 2.17% |
| Dec 31, 2003 | 22.49B | 1.04B | 4.85% |
| Dec 31, 2002 | 21.45B | 246.80M | 1.16% |
| Dec 31, 2001 | 21.20B | -19.16B | -47.48% |
| Dec 31, 2000 | 40.36B | 7.65B | 23.38% |
| Dec 31, 1999 | 32.71B | 5.82B | 21.62% |
| Dec 31, 1998 | 26.90B | 3.26B | 13.80% |
| Dec 31, 1997 | 23.64B | 3.81B | 19.21% |
| Dec 31, 1996 | 19.83B | 3.15B | 18.87% |
| Dec 31, 1995 | 16.68B | 1.71B | 11.43% |
| Dec 31, 1994 | 14.97B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 379.49B |
| Johnson & Johnson | 81.80B |
| AbbVie | 54.40B |
| Novartis AG | 49.92B |
| AstraZeneca | 47.61B |
| Thermo Fisher | 42.49B |
| Abbott Laboratories | 40.33B |
| Eli Lilly | 35.93B |
MRK News
- 3 days ago - Cramer says these 10 stocks helped the Dow briefly crack 40,000 - CNBC
- 5 days ago - Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline - Business Wire
- 7 days ago - Merck stops skin cancer combination therapy testing in late-stage study - Reuters
- 7 days ago - Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma - Business Wire
- 11 days ago - Merck treatment for a type of uterus cancer fails trial - Reuters
- 11 days ago - Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent - Business Wire
- 12 days ago - Merck to Participate in the Bank of America Securities 2024 Healthcare Conference - Business Wire
- 14 days ago - Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region - GlobeNewsWire